ThinkSabio

$GKOS

$244.88▲ 120.97% YTD

8 SEC 13D/G filings tracked · Last updated Nov 16, 2026

Filing History
SEC 13D/G
GKOS - Glaukos Corporation - SEC Filing Update (16-NOV-2026) | ThinkSabio - Stocks Simplified
$244.88▲ 120.97%Nov 16, 2026 · ThinkSabio Blog

$GKOS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #GKOS Glaukos Corporation : $244.88 Sector: Healthcare | YTD: 🔼+…

News
GKOS ▼ -0.1% - Glaukos Corporation
CP $238.61▲ -0.1%Nov 3, 2026 · ThinkSabio Blog

$GKOS - Glaukos Announces Participation in Upcoming Investor Conferences…

News
GKOS ▲ +9.2% - Glaukos Corporation
CP $198.00▲ +9.2%Oct 28, 2026 · ThinkSabio Blog

$GKOS - Glaukos Announces Third Quarter 2026 Financial Results…

News
GKOS ▲ +1.0% - Glaukos Corporation
CP $163.05▲ +1.0%Oct 9, 2026 · ThinkSabio Blog

$GKOS - Glaukos Announces Positive Topline Results from Phase 4 Prospective Randomized Controlled Clinical Trial Evaluating iDose® TR in Combination w…

News
GKOS ▼ -0.2% - Glaukos Corporation
CP $171.93▲ -0.2%Oct 8, 2026 · ThinkSabio Blog

$GKOS - Glaukos Announces Exclusive License Agreement with RevOpsis Therapeutics to Develop and Commercialize RO-104, a First-in-Class Tri-Specific Bi…

News
GKOS ▲ +8.5% - Glaukos Corporation
CP $175.37▲ +8.5%Oct 7, 2026 · ThinkSabio Blog

$GKOS - Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes in Keratoconus…

News
GKOS ▲ +8.5% - Glaukos Corporation
CP $175.37▲ +8.5%Oct 7, 2026 · ThinkSabio Blog

$GKOS Glaukos Announces Positive Three-Year Epioxa® Results Demonstrating Durable Clinical Outcomes in Keratoconus…

News
GKOS ▲ +0.0% - Glaukos Corporation
CP $159.86▲ +0.0%Sep 23, 2026 · ThinkSabio Blog

$GKOS - Glaukos Partners with NBA Champion Stephen Curry to Launch “Could it be KC?” Campaign to Raise Awareness of Keratoconus…